Funding for this research was provided by:
Youth Fund of China Institute for Radiation Protection (YQ22000725)
Article History
Received: 5 June 2024
Accepted: 28 July 2024
First Online: 9 August 2024
Declarations
:
: All authors have no conflict of interests/competing interests to disclose. This study was conducted in accordance with the ethical standards of the Drug Safety Evaluation Center in China Institute for Radiation, Acceptance number CIRP-IACUC-(G)2020068. The protocol was approved by the Drug Safety Evaluation Center in China Institute for Radiation on July 30, 2020.